Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study
HPB · 2025-04 · 27 (4) · 562-571
DOI: 10.1016/j.hpb.2024.12.024 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HPB, 2025-04. Verfasst von Jeffrey W Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlan…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatectomy, Neuroendocrine Tumors, Pancreaticoduodenectomy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Pancreatic resections for pancreatic neuroendocrine tumors (pNET) may experience a higher complication rate than for pancreatic ductal adenocarcinoma (PDAC). This study aimed to determine the rate of the novel composite "Ideal Outcome" measure after resection for pNET, using PDAC as reference. METHODS: This observational cohort study included all consecutive patients after pancreatic resection for pNET and PDAC using the nationwide Dutch Pancreatic Cancer Audit (2014-2021). The primary outcome was Ideal Outcome; absence of postoperative mortality, postoperative pancreatic fistulas (POPF) grade B/C, other major complications, prolonged length of stay, reoperations and readmissions. RESULTS: In total, 524 pNET and 2851 PDAC resections were included. The rate of Ideal Outcome was lower after resection for pNET (47.7% versus 55.7%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands; Amsterdam Center for Endocrine and Neuroendocrine Tumors (ACcENT),…
- Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands.
- Department of Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.
- Department of Surgery, Maastricht University Medical Center +, Maastricht, the Netherlands; School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, the Netherlands.
- Department of Surgery, Catharina Ziekenhuis, Eindhoven, the Netherlands.
- Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands.
Zitieren
APA
Chen, J. W., Augustinus, S. A., Bonsing, B. A., Bouwense, S. A. W., De Hingh, I. H. J. T., Van Eijck, C. H., Groot Koerkamp, B., Hendriks, T. E., Engelsman, A. F., Besselink, M. G., Nieveen van Dijkum, E. J. M., & Dutch Pancreatic Cancer Group (2025). Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study. HPB, 27(4), 562-571. https://doi.org/10.1016/j.hpb.2024.12.024
Vancouver
Chen JW, Augustinus SA, Bonsing BA, Bouwense SAW, De Hingh IHJT, Van Eijck CH, et al. Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study. HPB. 2025;27(4):562-571. doi:10.1016/j.hpb.2024.12.024
BibTeX
@article{Chen2025,
author = {Chen, Jeffrey W and Augustinus, Simone A and Bonsing, Bert A and Bouwense, Stefan A W and De Hingh, Ignace H J T and Van Eijck, Casper H and Groot Koerkamp, Bas and Hendriks, Tessa E and Engelsman, Anton F and Besselink, Marc G and Nieveen van Dijkum, Els J M and Dutch Pancreatic Cancer Group, Dutch Pancreatic Cancer Group},
title = {Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study},
journal = {HPB},
year = {2025},
volume = {27},
number = {4},
pages = {562--571},
doi = {10.1016/j.hpb.2024.12.024}
}
EUVIMED